Workflow
盟科药业(688373.SH)股东Best Idea、JSR及GPTMT拟合计减持不超6%股份

Core Viewpoint - The company, Amgen Pharmaceuticals (688373.SH), has announced that its shareholders, Best Idea, JSR, and GP TMT, plan to reduce their holdings by up to 39.3363 million shares, representing no more than 6% of the total share capital, primarily due to personal funding needs [1] Summary by Relevant Categories Shareholder Actions - Shareholders Best Idea, JSR, and GP TMT intend to reduce their holdings through centralized bidding and block trading [1] - The total number of shares to be reduced is up to 39.3363 million [1] Market Impact - The reduction in shares will be executed at market prices, indicating a potential impact on the stock's market performance [1] - The planned reduction reflects the shareholders' personal funding requirements rather than company performance issues [1]